« Previous
Next »
Leukemia Research
Volume 24, Issue 7
, Pages 595-596
, July 2000
Myelodysplastic syndrome and aplastic anemia — diagnostic and conceptual uncertainties
References
- Late haematological complications in severe aplastic anaemia. Br. J. Haematol. 1988;69:413–418
- Antithymocyte globulin for patients with myelodysplastic syndrome. Br. J. Haematol. 1997;99:699–705
- Cyclosporin A therapy in hypoplastic MDS patients and certain refractory anaemias without hypoplastic bone marrow. Br. J. Haematol. 1998;100:304–309
-
.
The pathophysiology of acquired aplastic anemia.
New Engl. J. Med. 1997;336:1365–12372
- Haematological response of patients with myelodysplastic syndrome to antithymocyte globulin is associated with a loss of lymphocyte-mediated inhibition of CFU-GM and alterations in T-cell receptor V beta profiles. Br. J. Haematol. 1998;102:1314–1322
- Paroxysmal nocturnal hemoglobinuria cells in patients with bone marrow failure syndromes. Ann. Intern. Med. 1999;131:401–408
- Paroxysmal nocturnal haemoglobinuria clones in patients with myelodysplastic syndromes. Br. J. Haematol. 1998;102:465–474
- . Comparative multi-color flow cymetric analysis of cell surface anntigens in bone marrow hematopoietic progenitors between refractoryanemia and aplastic anemia. Leuk. Res. 2000;24:359–366
- . et al: Hypoplastic myelodysplastic syndromes can be distinguished from acquired aplastic anemia by CD34 and PCNA immunostaining of bone marrow biopsy specimens. Am. J. Clin. Pathol. 1997;107:268–274
PII: S0145-2126(00)00026-6
© 2000 Elsevier Science Ltd. All rights reserved.
« Previous
Next »
Leukemia Research
Volume 24, Issue 7
, Pages 595-596
, July 2000
